Simultaneous perturbation of the MAPK and the PI3K/mTOR pathways does not lead to increased radiosensitization

被引：0
|
作者：
Sebastian Kuger
Michael Flentje
Cholpon S. Djuzenova
机构：
[1] University Hospital of Würzburg,Department of Radiation Oncology
来源：
Radiation Oncology | / 10卷
关键词：
AZD6244; NVP-BEZ235; Radiosensitivity; Cell cycle arrest; Apoptosis; Autophagy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?
    Stefani, Constantin
    Miricescu, Daniela
    Stanescu-Spinu, Iulia-Ioana
    Nica, Remus Iulian
    Greabu, Maria
    Totan, Alexandra Ripszky
    Jinga, Mariana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (19)
  • [32] Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence
    Xu, Yingxi
    Li, Na
    Xiang, Rong
    Sun, Peiqing
    TRENDS IN BIOCHEMICAL SCIENCES, 2014, 39 (06) : 268 - 276
  • [33] Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways
    Ba Lina
    Gao Jingquan
    Chen Yunping
    Qi Hanping
    Dong Chonghui
    Pan Hao
    Zhang Qianhui
    Shi Pilong
    Song Chao
    Guan Xueying
    Cao Yonggang
    Sun Hongli
    PHYTOMEDICINE, 2019, 58
  • [34] Dual targeting of pi3k/mTOR
    Fokas, E.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S43 - S43
  • [35] PI-103 and Sorafenib Inhibit Hepatocellular Carcinoma Cell Proliferation by Blocking Ras/Raf/MAPK and PI3K/AKT/mTOR Pathways
    Gedaly, Roberto
    Angulo, Paul
    Hundley, Jonathan
    Daily, Michael F.
    Chen, Changguo
    Koch, Alvaro
    Evers, B. Mark
    ANTICANCER RESEARCH, 2010, 30 (12) : 4951 - 4958
  • [36] PI-103 and Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo by Blocking Ras/Raf/MAPK and PI3K/AKT/mTOR Pathways
    Gedaly, Roberto
    Angulo, Paul
    Hundley, Jonathan
    Daily, Michael F.
    Chen, Changguo
    Koch, Alvaro
    Evers, B. Mark
    LIVER TRANSPLANTATION, 2011, 17 (06) : S87 - S87
  • [37] Lymphatically directed MAPK/PI3K/mTOR inhibitor for treatment of cancer growth and metastasis
    Galban, Stefanie
    Espinoza, Carlos
    Luker, Kathryn E.
    Luker, Gary D.
    Van Dort, Marcian
    Ross, Brian D.
    CANCER RESEARCH, 2018, 78 (13)
  • [38] PI3K cooperates with MAPK to regulate mTOR signaling during lacrimal gland development
    Wang, Qian
    Hannan, Abdul
    Yoon, Sungtae
    Zhang, Xin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [39] Targeting EGFR and PI3K/mTOR pathways in glioblastoma: innovative therapeutic approaches
    Singh, Gursimran
    Rohit, Pankaj
    Kumar, Pankaj
    Aran, Khadga Raj
    MEDICAL ONCOLOGY, 2025, 42 (04)
  • [40] Inhibition of the PI3K and mTOR pathways reverses gemcitabine resistance in pancreatic cancer
    Chung, Vincent
    Gaur, Shikha
    Ann, David
    Yen, Yun
    CANCER RESEARCH, 2011, 71
12345